Description

Developed by the American Academy of Otolaryngology–Head and Neck Surgery. Endorsed by the American Academy of Audiology.

Key Points

The primary purposes of this guideline are to improve the quality of care and outcomes for benign paroxysmal positional vertigo (BPPV) by improving the accurate and efficient diagnosis of BPPV, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary testing such as radiographic imaging, and increasing the use of appropriate therapeutic repositioning maneuvers. 

The guideline is intended for all clinicians who are likely to diagnose and manage patients with BPPV, and it applies to any setting in which BPPV would be identified, monitored, or managed. The target patient for the guideline is aged ≥18 years with a suspected or potential diagnosis of BPPV.

Get Involved

Whether serving on a clinical document development panel or participating as peer reviewers, volunteers have regular chances to deepen their engagement with the Academy and make important contributions benefiting the field of audiology. If you are interested in clinical document development, please volunteer to express interest and submit a CV to the Academy’s guidelines staff by email.

To view the list of guidelines and strategic documents in development and to learn more about the Academy’s clinical document development process, visit the Academy’s Practice Resources website. Information from interested members is accepted on an ongoing basis, and members will be contacted as clinical document volunteer openings occur.

Share this

Related Content

Position Statement on the Audiologist’s Role in the Diagnosis and Treatment of Vestibular Disorders

Vestibular problems may affect individuals throughout the life cycle and may occur in infants as well as elderly individuals. Vestibular disorders may be due to syndromes, disease, toxins, or trauma.

Read More